Menno C van Zelm Marsus Pumar Peter Shuttleworth Pei M Aui Joanne M Smart Andrew Grigg Julian J Bosco
10.3389/fimmu.2019.00895
Front Immunol
2019 Apr 26;10:895.
btk igg x-linked agammaglobulinemia allogeneic stem cell transplantation pre-b-all vaccination response
CC BY
https://pubmed.ncbi.nlm.nih.gov/31105705/
Agammaglobulinemia / genetics Genetic Diseases, X-Linked / genetics Hematopoietic Stem Cell Transplantation Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy Tumor Suppressor Protein p53 / genetics
Agammaglobulinemia / genetics Genetic Diseases, X-Linked / genetics Hematopoietic Stem Cell Transplantation Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy Tumor Suppressor Protein p53 / genetics Case Reports Research Support, Non-U.S. Gov't Adult Cyclosporine / therapeutic use Graft vs Host Disease / prevention & control Humans Immunoglobulin A / blood Immunoglobulin G / blood Immunoglobulin M / blood Immunosuppressive Agents / therapeutic use Male Prednisolone / therapeutic use Transplantation Conditioning Immunoglobulin A Immunoglobulin G Immunoglobulin M Immunosuppressive Agents TP53 protein, human Tumor Suppressor Protein p53 Cyclosporine Prednisolone Bruton type agammaglobulinemia
PMC6498405
31105705
Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for TP53 Mutant pre-B-ALL in a Patient With X-Linked Agammaglobulinemia
2019